Vasomotor Symptoms
📧 Sign up to get email alerts when something new happens for Vasomotor Symptoms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause (OASIS-2) [Phase 3]
Phase 3 trial update for elinzanetant in vasomotor symptoms associated with menopause; the OASIS-2 study has completed and results have been…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Effect of IMB Model-Based Education for Women With Menopausal Hot Flashes [NA]
Clinical trial update on Marmara University study assessing IMB Model-Based Education for women with menopausal hot flashes; the study is cu…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Transcranial Electrical Stimulation for Noninvasive Study of Menopausal/Perimenopausal Symptoms [NA]
This clinical trial update describes a noninvasive study using transcranial electrical stimulation to investigate menopausal and perimenopau…
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: A Study to Investigate Relative Bioavailability, Safety and Tolerability of Single- and Multiple-doses of Elinzanetant in Healthy Female Participants [Phase 1]
Phase 1 study evaluating the relative bioavailability, safety and tolerability of single- and multiple-doses of Elinzanetant in healthy fema…
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort II) [Phase 3]
Phase 3 E4Comfort II trial evaluating estetrol for moderate-to-severe vasomotor symptoms in postmenopausal women has completed and results h…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: A Trial to Investigate the Accuracy of a Wearable Device in Collecting Data Related to Perimenopausal Symptoms in Women
A clinical trial is currently recruiting to assess the accuracy of a wearable device in collecting data on perimenopausal symptoms in women.
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Safety and Efficacy of Asimadoline (TP0052) in Patients With Vasomotor Symptoms (VMS). [Phase 2]
A Phase 2 clinical trial is evaluating the safety and efficacy of asimadoline (TP0052) for vasomotor symptoms and is currently recruiting.
-
CLINICAL_TRIALS withdrawal · 2025-07-23Clinical Trial Update: Stellate Ganglion Blockade in Post-Menopausal Women [Phase 2]
A Phase 2 clinical trial evaluating stellate ganglion blockade for vasomotor symptoms in postmenopausal women has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-07-14Clinical Trial Update: A Study to Learn How Elinzanetant Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Kidneys That do Not Work as Well as They Should Compared to Participants Whose Kidneys Work Normally [Phase 1]
Phase 1 study evaluating pharmacokinetics, safety, and physiological effects of elinzanetant in participants with different kidney function;…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Hot Flashes and Neurovascular Function in Women [NA]
Mayo Clinic is recruiting participants for a clinical study examining hot flashes and neurovascular function during menopause.
-
FDA approval · 2025-04-29FDA Approved: DIVIGEL — Supplemental Application (Vertical Pharmaceuticals, LLC)
The FDA approved a supplemental application for Divigel (estradiol) from Vertical Pharmaceuticals, LLC. The approval updates the product lab…
-
CLINICAL_TRIALS research · 2025-02-05Clinical Trial Update: Influence of Iyengar Yoga on the Bio-functional Age of Postmenopausal Women [NA]
This clinical trial update reports that Insel Gruppe AG and University Hospital Bern are recruiting a study to assess whether Iyengar Yoga c…
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I) [Phase 3]
Phase 3 clinical trial (E4Comfort Study I) assessing estetrol for moderate to severe vasomotor symptoms in postmenopausal women has complete…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Study of DARE-HRT1 Over 12 Weeks in Healthy PostMenopausal Women [Phase 1, Phase 2]
Results from a completed Phase 1/2 trial of DARE-HRT1 over 12 weeks in healthy postmenopausal women have been posted. The study targeted vul…
-
CLINICAL_TRIALS trial_result · 2024-10-26Clinical Trial Update: A Study of Fezolinetant to Treat Hot Flashes in Women Going Through Menopause [Phase 3]
A Phase 3 trial of fezolinetant for vasomotor symptoms in menopausal women has completed.
-
CLINICAL_TRIALS research · 2024-10-26Clinical Trial Update: A Survey About Hot Flashes in Women Going Through the Menopause
A completed survey-based clinical trial update by Astellas Pharma Europe Ltd. studying hot flashes in menopausal women.
-
FDA approval · 2024-08-02FDA Approved: LYLLANA — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for LYLLANA (estradiol) submitted by Amneal Pharmaceuticals LLC.
-
CLINICAL_TRIALS research · 2024-05-29Clinical Trial Update: Efficacy of Nano-Pso Therapy in Menopause [NA]
A clinical trial evaluating Nano-Pso Therapy for menopause-related symptoms is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: A Study to Learn if Elinzanetant Affects the Ability to Drive and Brain Function in Healthy Women [Phase 1]
A Phase 1 clinical trial update reports the completion of a study evaluating whether elinzanetant affects driving ability and brain function…
-
CLINICAL_TRIALS research · 2024-05-01Clinical Trial Update: A Study to Find the Best Dose of HS-10384 to Treat Vasomotor Symptoms in Postmenopausal Women [Phase 2]
Clinical trial update describing a Phase 2 study to identify the best dose of HS-10384 for treating vasomotor symptoms in postmenopausal wom…
-
FDA approval · 2024-02-15FDA Approved: BIJUVA — Supplemental Application (Mayne Pharma)
The FDA approved a supplemental application for BIJUVA, a combination of estradiol and progesterone, submitted by Mayne Pharma. The approval…
-
CLINICAL_TRIALS trial_result · 2023-05-23Clinical Trial Update: HIRREM Hot Flashes Study [NA]
Clinical trial update for the HIRREM hot flashes study shows completed status with posted results.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Efficacy and Safety of Oxybutynin Versus Paroxetine in Aromatase Inhibitor-induced Vasomotor Symptoms [Phase 3]
A Phase 3 trial comparing oxybutynin to paroxetine for vasomotor symptoms induced by aromatase inhibitors; efficacy and safety data are not …
-
CLINICAL_TRIALS trial_result · 2022-10-03Clinical Trial Update: Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms [Phase 2]
Phase 2 long-term safety and efficacy study of MT-8554 for vasomotor symptoms in postmenopausal women has completed, with results posted in …
-
CLINICAL_TRIALS trial_result · 2022-06-03Clinical Trial Update: Effects of Stellate Ganglion Block on Hot Flashes in Hispanic Women With Breast Cancer [Phase 2]
Phase 2 clinical trial investigating stellate ganglion block for hot flashes in Hispanic women with breast cancer; status terminated with re…